Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 2 Tumor-Agnostic 1 Other hematologic neoplasm 1 Lymphoid 1 Gynecologic 1 CNS 1

Conditions

Ovarian Neoplasms 1

Interventions

pembrolizumab 45 Paclitaxel 45 Carboplatin 39 Magnetic Resonance Spectroscopy 28 olaparib 27 Specimen Handling 26 Cisplatin 24 Bevacizumab 20 Nivolumab 18 Taxes 17 Biopsy 16 Gemcitabine 13 Cyclophosphamide 13 durvalumab 12 Immunoglobulin G 11 Doxorubicin 11 Disulfides 11 Surveys and Questionnaires 10 niraparib 9 liposomal doxorubicin 9 dostarlimab 9 Radiotherapy 8 Brachytherapy 8 lenvatinib 7 fludarabine 7 atezolizumab 7 Letrozole 7 Docetaxel 7 cediranib 6 Platinum 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × neratinib × Gynecologic × Clear all

NCT04502602 2026-05-11

iNNOVATE

Virginia Commonwealth University

Phase 1 Active not recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡